CD8A and neoplasm: Mice treated with the combination therapy had higher percentages of tumor‐infiltrating CD8+ T‐cells and CD4+ T‐cells in both injected and non‐injected tumors compared with mice treated with either control or 2′3′‐cGAMP (Fig. 4A,B).